OpenVSafe by OpenVAERS
Search V-safe

E3T-12339-28989

2 vaccinations 8 coded responses 23 check-ins 8 free-text entries 1 call case
Sex
Male
Age at first dose
46-50
ZIP prefix
080 / NJ
Registered
2021-01-27
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-26
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-27
    Registered in v-safe
  3. 2021-01-27
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness, Dry eye, Dry mouth — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: dry mouth, dry eye, light headed.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches
    Adult check-in
  5. 2021-01-29
    Survey response — days 1–6 daily, dose 1
    MedDRA: Parosmia — Feeling: Good · Site: Pain
    Free text: phantom odor-peanuts
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-01-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-02
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-09
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-16
    Dose 2 — Pfizer-BioNTech
  12. 2021-02-16
    Health check-in — day 0, dose 2
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  13. 2021-02-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  14. 2021-02-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  15. 2021-02-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  16. 2021-02-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Muscle or body aches
    Adult check-in
  17. 2021-02-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Muscle or body aches
    Adult check-in
  18. 2021-02-23
    Survey response — day 7, dose 2
    MedDRA: Dysgeusia — Feeling: Good
    Free text: sense of taste is off
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-03-02
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-03-09
    Survey response — day 21, dose 2
    MedDRA: Fatigue, Myalgia — Feeling: Fair
    Free text: Lingering muscle soreness.Unable to stop feeling fatigued.Neither symptom. Is severe but is annoying in that they have not faded.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-03-18
    Survey response — day 28, dose 2
    MedDRA: Fatigue, Parosmia — Feeling: Fair
    Free text: Very high fatigue levels. Altered and/or missing odors and flavors.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-03-25
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  23. 2021-03-30
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  24. 2021-05-18
    Survey response — 3 months, dose 2
    MedDRA: Dyspnoea, Fatigue, Myalgia — Feeling: Fair
    Free text: Shortness of breath, muscle soreness, chronic fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-08-17
    Survey response — 6 months, dose 2
    MedDRA: Disturbance in attention, Dyspnoea, Fatigue, Hyperhidrosis, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional
    Free text: Symptoms: SOB, chronic fatigue, sweats, difficulty with mental focus · Healthcare visit (other): Lab panel, echo, ecg
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  26. 2021-08-17
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  27. 2021-12-10
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  28. 2022-02-16
    Survey response — 12 months, dose 2
    MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Positive for covud 19
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-01-26Pfizer-BioNTech
22021-02-16Pfizer-BioNTech

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 1

2021-01-27

Systemic reaction (other): dry mouth, dry eye, light headed.

Release 3 — days 1–6 daily, dose 1

2021-01-29

Systemic reaction (other): phantom odor-peanuts

Release 4 — day 7, dose 2

2021-02-23

Systemic reaction (other): sense of taste is off

Release 5 — day 21, dose 2

2021-03-09

Symptoms: Lingering muscle soreness.Unable to stop feeling fatigued.Neither symptom. Is severe but is annoying in that they have not faded.

Release 5 — day 28, dose 2

2021-03-18

Symptoms: Very high fatigue levels. Altered and/or missing odors and flavors.

Release 8 — 3 months, dose 2

2021-05-18

Symptoms: Shortness of breath, muscle soreness, chronic fatigue

Release 9 — 6 months, dose 2

2021-08-17

Symptoms: SOB, chronic fatigue, sweats, difficulty with mental focus
Healthcare visit (other): Lab panel, echo, ecg

Release 11 — 12 months, dose 2

2022-02-16

Symptoms: Positive for covud 19

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event ✓ · ✓
SDCOVID-19 · · ✓
SDDisturbance in attention ✓ · ✓
SDDyspnoea ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHyperhidrosis ✓ · ✓
SDMyalgia ✓ ✓ ✓
SDParosmia ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SRODry eye ✓ ✓ ✓
SRODry mouth ✓ ✓ ✓
SRODysgeusia ✓ ✓ ✓
SROParosmia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release